Transgenic mouse models of lymphoma for preclinical analysis of novel anti-cancer drugs.

被引:0
|
作者
Pedersen, IM
Zapata, JM
Sporn, M
Carson, DA
Leoni, LM
Reed, JC
机构
[1] Burnham Inst, La Jolla, CA 92037 USA
[2] Dartmouth Coll Sch Med, Hanover, NH USA
[3] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[4] Salmedix Inc, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1365
引用
收藏
页码:352A / 352A
页数:1
相关论文
共 50 条
  • [1] Novel ceramide analogs are new anti-cancer drugs.
    Bieberich, E
    Hu, B
    Silva, J
    MacKinnon, S
    Yu, RK
    Ottenbrite, RM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U432 - U432
  • [2] Development of immunoproteasome-specific inhibitors as novel anti-cancer drugs.
    Kuhn, Deborah J.
    Voorhees, Peter M.
    Chen, Qing
    Strader, John S.
    Bruzzese, Frank
    Ciavarri, Jeffrey P.
    Hu, Zhigen
    Orlowski, Robert Z.
    BLOOD, 2006, 108 (11) : 986A - 987A
  • [3] AN ANALYSIS OF THE MAJOR CLEARANCE MECHANISMS OF COMMONLY PRESCRIBED ANTI-CANCER DRUGS.
    Loi, C.
    Jani, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S78 - S78
  • [4] Transgenic mouse models generated by hydrodynamic transfection for genetic studies of liver cancer and preclinical testing of anti-cancer therapy
    Ju, Hye-Lim
    Han, Kwang-Hyub
    Lee, Jong Doo
    Ro, Simon Weonsang
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (07) : 1601 - 1608
  • [5] Glycoprotein glycosylation: Targets for new anti-cancer drugs.
    Dennis, JW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 38 - CARB
  • [6] Simple organotin polyethers as potential anti-cancer drugs.
    Siegmann-Louda, D
    Carraher, CE
    Nagy, D
    Snedden, D
    Ross, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U505 - U505
  • [7] Developing methods towards the synthesis of precursors for anti-cancer drugs.
    Paschal, RW
    DiCesare, JC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U135 - U135
  • [8] Palmitoyl-acyltransferases as new targets for anti-cancer drugs.
    Ducker, CE
    Stettler, EM
    Smith, RA
    Griffel, LK
    Keller, SW
    Smith, CD
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9148S - 9148S
  • [9] Novel drug resistant CDX models for anti-cancer drugs discovery
    Dai, Hai-Ting
    Bing, Tie-Jun
    An, Zhi-Da
    Yang, Jie
    Pang, Tian-Yu
    Gao, Jia-Wei
    Bo, Yun-Yi
    Yu, Wen-Jen
    CANCER RESEARCH, 2024, 84 (06)
  • [10] Clinical evidence and benefit of special FDA designations in anti-cancer drugs.
    Michaeli, Daniel Tobias
    Michaeli, Julia Caroline
    Albers, Sebastian
    Boch, Tobias
    Winterhoff, Boris
    Michaeli, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)